|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"chiun sheng huang"
Showing items 351-360 of 438 (44 Page(s) Totally)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Metaplastic carcinoma of the breast-analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer
|
Kuo, S.-H.; Chen, C.-L.; Huang, C.-S.; Cheng, A.-L.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Ultrasound-guided mammotome biopsy of breast lesions in Taiwanese women
|
Lin, J.-H. and Guo, W.-H. and Huang, C.-S. and Chang, K.-J. and Shih, J.-C. and Hsieh, F.-J.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Utility assessment for different clinical phases of breast cancer in Taiwan
|
CHIUN-SHENG HUANG; CHIE, WEI-CHU; HUANG, CHIUN-SHENG; CHEN, JEN-HAU; CHANG, KING-JEN; Chie, W.-C. and Huang, C.-S. and Chen, J.-H. and Chang, K.-J.; CHIE, WEI-CHU;HUANG, CHIUN-SHENG;CHEN, JEN-HAU;CHANG, KING-JEN; 季瑋珠;黃俊升;陳人豪;張金堅 |
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis
|
CHIUN-SHENG HUANG; Shen, C.-Y. and Yu, J.-C. and Lo, Y.-L. and Kuo, C.-H. and Yue, C.-T. and Jou, Y.-S. and Huang, C.-S. and Lung, J.-C. and Wu, C.-W. |
| 臺大學術典藏 |
2018 |
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer
|
Chen S.; CHIUN-SHENG HUANG; Cui Y.X.; Somlo G.; Kanaya N.; Lo C.; Nguyen D.; Petrossian K.;Nguyen D.;Lo C.;Kanaya N.;Somlo G.;Cui Y.X.;Chiun-Sheng Huang;Chen S.; Petrossian K. |
| 臺大學術典藏 |
2018 |
Effect of glucocorticoid use on survival in patients with stage I–III breast cancer
|
Lin C.-H.;Chuang P.-Y.;You S.-L.;Chiang C.-J.;Chiun-Sheng Huang;Wang M.-Y.;Chao M.;Lu Y.-S.;Cheng A.-L.;Tang C.-H.; Chuang P.-Y.; You S.-L.; Chiang C.-J.; CHIUN-SHENG HUANG; Wang M.-Y.; Chao M.; Lu Y.-S.; Cheng A.-L.; Tang C.-H.; Lin C.-H. |
| 臺大學術典藏 |
2018 |
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
|
Kruper L.; Yuan Y.; Somlo G.; Mortimer J.; Chen S.; Petrossian K.; Kanaya N.; Lo C.; Hsu P.-Y.; Nguyen D.; Yang L.; Yang L.; Warden C.; Wu X.; Pillai R.; Bernal L.; CHIUN-SHENG HUANG; Petrossian K.;Kanaya N.;Lo C.;Hsu P.-Y.;Nguyen D.;Yang L.;Yang L.;Warden C.;Wu X.;Pillai R.;Bernal L.;Chiun-Sheng Huang;Kruper L.;Yuan Y.;Somlo G.;Mortimer J.;Chen S. |
| 臺大學術典藏 |
2018 |
Computer-Aided tumor diagnosis in 3-D breast elastography
|
Huang Y.-S.;Takada E.;Konno S.;Chiun-Sheng Huang;Kuo M.-H.;Chang R.-F.; Huang Y.-S.; Takada E.; Konno S.; CHIUN-SHENG HUANG; Kuo M.-H.; Chang R.-F. |
| 臺大學術典藏 |
2018 |
Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al.
|
on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; Xu B.; Whelan T.J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Cuzick J.; Denkert C.; Di Leo A.; Ejlertsen B.; Francis P.; Galimberti V.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; Hayes D.F.; CHIUN-SHENG HUANG; Huober J.; Khaled H.; Jassem J.; Jiang Z.; Karlsson P.; Morrow M.; Orecchia R.; Osborne K.C.; Pagani O.; Partridge A.H.; Pritchard K.; Ro J.; Rutgers E.J.T.; Sedlmayer F.; Semiglazov V.; Shao Z.; Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Bergh J.; Baselga J.; Thrlimann B.; Andr? F.; Senn H.-J.; Piccart-Gebhart M.; Regan M.M.; Colleoni M.; Loibl S.; Gnant M.; Winer E.P.; Burstein H.J.; Curigliano G.; Dubsky P.; Dubsky P.;Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Loibl S.;Colleoni M.;Regan M.M.;Piccart-Gebhart M.;Senn H.-J.;Thrlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;Hayes D.F.;Chiun-Sheng Huang;Huober J.;Khaled H.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B.;On Behalf Of The Panel Members Of The St Gallen International Expert Consensus On The Primary Therapy Of Early Breast Cancer 2017 |
| 臺大學術典藏 |
2017 |
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
|
Ataseven, B.; Verrill, M.; De Laurentiis, M.; Jung, K.H.; Azim, H.A.; Al-Sakaff, N.; Lauer, S.; Shing, M.; Pivot, X.; Koroveshi, D.; Bouzid, K.; Casalnuovo, M.; Cascallar, D.; Korbenfeld, E.P.; Bastick, P.; Beith, J.; Colosimo, M.; Friedl; er, M.; Ganju, V.; Green, M.; Patterson, K.; Redfern, A.; Richardson, G.; Ceric, T.; Gordana, K.; Beato, C.A.; Ferrari, M.; Hegg, R.; Helena, V.; Ismael, G.F.; Lessa, A.E.; Mano, M.; Morelle, A.; Nogueira, J.A.; Timcheva, K.; Tomova, A.; Tsakova, M.; Zlatareva-Petrova, A.; Asselah, J.; Assi, H.; Brezden-Masley, C.; Chia, S.; Freedman, O.; Harb, M.; Joy, A.A.; Kulkarni, S.; Prady, C.; Gaete, A.A.A.; Matamala, L.; Torres, R.; Yanez, E.; Franco, S.; Urrego, M.; Gugi?, D.; Vrbanec, D.; Melichar, B.; Prausov; CHIUN-SHENG HUANG |
Showing items 351-360 of 438 (44 Page(s) Totally)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
View [10|25|50] records per page
|
